Pete De Spain | Vice President, Investor Relations |
Troy Wilson | President and Chief Executive Officer |
Heidi Henson | Chief Financial Officer |
Antonio Gualberto | Head, Development and Chief Medical Officer |
Jonathan Chang | Leerink Partners |
Konstantinos Aprilakis | JMP Securities |
Pam Barendt | Cowen |
Good day, ladies and gentlemen and welcome to the Q1 2018 Kura Oncology, Inc. Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Pete De Spain, Vice President, Investor Relations. Please go ahead.
Thank you, operator.